CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Casi Pharmaceuticals, Inc.  (CASI)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
 

Casi Pharmaceuticals's Leverage Ratio

CASI's quarterly Leverage Ratio and Total Liabilities, Equity growth


Select the Comparisons : Select the Ratio:                        

CASI Leverage Ratio (Mar 31 2017)
I. Quarter
(Dec 31 2016)
IV. Quarter
(Sep 30 2016)
III. Quarter
(Jun 30 2016)
II. Quarter
(Mar 31 2016)
I. Quarter
Y / Y Equity Change 314.96 % - - - -
Y / Y Total Liabilities Change -29.79 % -41.84 % -26.2 % -25.64 % -17.68 %
Leverage Ratio MRQ 0.36 0.33 0.55 0.89 2.13
Overall Ranking # 657 # 634 # 994 # 1634 # 2947
Seq. Equity Change -7.43 % 29.71 % 59.85 % 116.19 % -
Seq. Total Liabilities Change 0.19 % -20.67 % -2.35 % -9.55 % -17 %



Leverage Ratio first quarter 2017 Comment
Due to net new borrowings of 0.19%, Leverage Ratio detoriated to 0.36, below company's average Leverage Ratio.

Within Biotechnology & Drugs industry in the first quarter 2017, 58 other companies have achieved lower Leverage Ratio than Casi Pharmaceuticals. While Leverage Ratio total ranking has deteriorated compare to previous quarter from 634 to 657.

Explain Leverage Ratio?
Who are CASI Customers?
Leverage Ratio first quarter 2017 Company Ranking
Within: No.
Industry # 59
Sector # 228
S&P 500 # 657


Leverage Ratio Statistics
High Average Low
13.82 2.59 0.06
(Sep 30 2014)   (Jun 30 2014)


You need to upgrade your Flash Player


Financial Statements
Casi Pharmaceuticals's Equity $ 19 Millions Visit CASI's Balance sheet
Casi Pharmaceuticals's Total Liabilities $ 7 Millions Visit CASI's Balance sheet
Source of CASI's Sales Visit CASI's Sales by Geography




Companies with similar Leverage Ratio in the quarter endingMar 31 2017, within Biotechnology & Drugs Industry Leverage RatioMar 31 2017 MRQ Total LiabilitiesMar 31 2017 MRQ Equity
Assembly Biosciences, Inc.  0.98 $ 66.396  Millions$ 67.888  Millions
Aviragen Therapeutics, Inc.  0.93 $ 22.500  Millions$ 24.200  Millions
Aytu Bioscience, Inc  0.87 $ 7.395  Millions$ 8.521  Millions
Biogen Inc.  0.85 $ 9,716.900  Millions$ 11,467.400  Millions
Acorda Therapeutics Inc  0.84 $ 567.585  Millions$ 676.127  Millions
Alliance Bioenergy Plus, Inc.  0.72 $ 3.712  Millions$ 5.170  Millions
Neuralstem, Inc.  0.69 $ 6.781  Millions$ 9.780  Millions
Bio-techne Corp  0.69 $ 625.506  Millions$ 907.925  Millions
Dimension Therapeutics, Inc.  0.65 $ 30.738  Millions$ 47.489  Millions
Repligen Corp  0.64 $ 113.837  Millions$ 176.791  Millions
Cv Sciences, Inc.  0.63 $ 7.439  Millions$ 11.735  Millions
Eiger Biopharmaceuticals, Inc.  0.61 $ 18.897  Millions$ 30.870  Millions
Genocea Biosciences, Inc.  0.61 $ 20.121  Millions$ 33.084  Millions
Marina Biotech, Inc.  0.58 $ 1.973  Millions$ 3.419  Millions
Aeolus Pharmaceuticals, Inc.  0.57 $ 0.638  Millions$ 1.127  Millions
Emergent Biosolutions Inc.  0.56 $ 339.004  Millions$ 610.419  Millions
Aptevo Therapeutics Inc.  0.55 $ 33.997  Millions$ 61.486  Millions
Citius Pharmaceuticals, Inc.  0.52 $ 7.343  Millions$ 13.992  Millions
Pdl Biopharma, Inc.  0.51 $ 390.577  Millions$ 762.936  Millions
Crispr Therapeutics Ag  0.50 $ 107.171  Millions$ 215.175  Millions
Relmada Therapeutics, Inc.  0.49 $ 1.368  Millions$ 2.802  Millions
Microbot Medical Inc.  0.46 $ 1.788  Millions$ 3.889  Millions
Soligenix, Inc.  0.45 $ 2.593  Millions$ 5.816  Millions
Heska Corp  0.44 $ 40.867  Millions$ 92.698  Millions
Pulmatrix, Inc.  0.43 $ 6.892  Millions$ 15.902  Millions
Voyager Therapeutics, Inc.  0.43 $ 52.393  Millions$ 122.697  Millions
Uluru Inc.  0.41 $ 3.076  Millions$ 7.580  Millions
Tracon Pharmaceuticals, Inc.  0.40 $ 9.230  Millions$ 22.988  Millions
Intellia Therapeutics, Inc.  0.40 $ 79.380  Millions$ 199.883  Millions
Myokardia Inc  0.36 $ 49.169  Millions$ 135.247  Millions
Economy

Advance Monthly Sales
Consumer Price Index CPI
Producer Price Index PPI
Retail Inventories
Personal Income
Gross Domestic Product GDP
Money Supply
Industrial Production
Productivity
Employment Situation
US International Trade
Factory Orders
Durable Goods
Construction Spending
Housing Starts
Vehicle Unit Sales
Stocks

Event Calendar
MADL's Profile
Stock Price
MADL's Financials
MADL's Expectations
Business Description
Fundamentals
Charts & Quotes
MADL's News
Suppliers
MADL's Competitors
Customers & Markets
Economic Indicators
MADL's Growth
Company Segments
Industries

At a Glance
Performance
Growth Rates
Profitability
Valuation
Financial Strength
Markets

At a Glance
Stocks
Indices
Sectors & Industries
Financials
Commodities
Currencies
Screening

Stock Performance
Growth Rates
Profitability
Valuation
Dividend
Financial Strength
Efficiency
Expectations
Management Effectivness
News

At a Glance
Stocks
Economy
Industries
Other
Glossary

Financial Terms
Technical Analysis
Fundamental Analysis
Energy Terms
Manufacturing Terms
Transportation Terms
Health Care
Insurance Terms
Economy Terms
Hotel & Leisure Terms
Help

Sitemap
Advertise
About us
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com